Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Dan Barouch tells us about his time in Oxford, as a DPhil student in Professor Andrew McMichael's lab. He also comments on how we do as a field trying to develop HIV vaccines - overall not great since we don't have a vaccine yet, and we have tested only 3 conceps over the last 30 years.

Professor Barouch has demonstrated that cellular immune responses can partially control viral replication. This means that HIV-1 vaccines that generate potent cellular immune responses may provide important benefits even if they fail to afford sterilizing immunity. Professor Barouch has developed chimeric adenovirus vectors, and has advanced these vectors into preclinical studies and phase 1 clinical trials.

Professor Dan Barouch

HIV vaccines

dan-headshot.jpgProfessor Dan Barouch is Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, Harvard Medical School. After graduating from Harvard Medical School, Dan Barouch earned a DPhil in immunology at the University of Oxford. A world leader in the field of HIV research, Professor Barouch studies the immunology and virology of HIV-1 infection, and develops novel vaccine strategies for the virus. He leads a large programme that has developed a series of novel and promising HIV-1 vaccine candidates, which are currently in clinical trials, both in the USA and in sub-Saharan Africa.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.